RECURRENT LEUKEMIA
Clinical trials for RECURRENT LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemias: experimental drug combo enters human testing
Disease control OngoingThis early-phase trial tests a new drug called tegavivint, combined with decitabine, in 9 adults with leukemia that has come back or not responded to standard treatments. The goal is to find the safest dose and see if the combination can control the disease. Participants must hav…
Matched conditions: RECURRENT LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Cancer weight loss study also targets caregiver stress
Knowledge-focused OngoingThis study measures how often cancer patients in a supportive care clinic experience cachexia (unintentional weight loss and appetite loss) and examines the emotional toll on both patients and their primary caregivers. Researchers will track weight changes and use questionnaires …
Matched conditions: RECURRENT LEUKEMIA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC